| abstract |
The ophthalmic and / or neurological disease of the human or veterinary object was selected from urea, urea derivatives, thiourea, thiourea derivatives, guanidines, guanidine derivatives and compounds having general formula I as disclosed herein A method of treatment by administering a therapeutically effective amount of a compound. In ophthalmic applications, the compounds can be delivered by intravitreal injection to induce vitreal liquefaction, posterior vitreous retinal detachment and other effects. |